+(91) 79 4891 1722



Doxercalciferol is drug forsecondary hyperparathyroidism and metabolic bone disease. Doxercalciferol is asynthetic form of vitamin D. This medication is used to treat people withserious kidney disease who have high levels of a certain natural substance(parathyroid hormone-PTH), High PTH levels affect the balance of other mineralsin your body (calcium and phosphorus) and may result in weak bones.

Ralington pharma LLP (India), a globalmanufacturer and supplier for Doxercalciferol, 54573-75-0 for R&D, Pilot orCommercials  Quantities withPharmacopeial Grade USP/ EP/ BP/ IP/ JP/In-House.

Doxercalciferol, 54573-75-0 availablewith USDMF,EDMF, DMF, USFDA, EUGMP, GMP,ISO CERTIFIED,WHO-GMP and DMF as per the requirement. Product supply inStandard Packaging & labeling as per FDA along with supportivedocumentation. We can also offer Intermediates of  Doxercalciferol, 54573-75-0.

ProductType : API
Molecular Formula : C28H44O2
CASNo : 54573-75-0
Grades : CTD,USP,BP,EP,DMF,GMP,USDMF,EDMF,Technical Package
Molecular Weight : 412.65
Synonym : (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol,,,

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).